The important question about Trinity Meds is not simply how quickly someone can complete its advertised two-minute assessment. It is what happens afterward: who reviews the information, who makes the prescribing decision, which pharmacy fills a prescription and who handles a delivery problem. Trinity Meds markets a connected experience, but its public documentation divides responsibility among the commercial platform, OpenLoop-related clinical practices and outside pharmacies. Understanding those handoffs is essential before treating the advertised monthly price or delivery estimate as a complete description of care.
This review examines public documentation consulted October 19, 2026, rather than firsthand treatment. Trinity Meds documents access, when clinically appropriate, to compounded injectable semaglutide or tirzepatide. It also publishes meaningful details about consultation formats, support channels, pharmacy options and subscription rules. The limitations are equally specific: promotional and policy pages disagree about several important points, and the documents do not establish the exact formulation or quantity attached to each advertised price. The following review follows the service from entry through ongoing care, highlighting where a patient needs a clearer written answer.
At a glance
- Who delivers care
- Trinity Meds describes a nonclinical role; OpenLoop Healthcare Partners, PC and affiliated practices provide clinical evaluation and prescribing, while outside pharmacies dispense.
- Documented treatment
- The membership describes compounded semaglutide and compounded tirzepatide in injectable formulations, prescribed only when a clinician finds treatment appropriate.Sources: [3]
- Advertised prices
- Pages advertise GLP-1 from $99 per month and GLP-1/GIP from $149 per month, alongside conflicting fixed-price and price-increase messaging.
- Delivery estimates
- Advertising mentions arrival in 1–2 days, while the FAQ describes typical processing and delivery of approximately 4–5 business days.
Start by separating the platform from the clinical practice
Trinity Meds, Inc. operates the website, while the terms identify Openloop, Inc. as operator of the telehealth technology platform, also called CareGLP. Those companies are described as separate legal entities with distinct roles. The clinical notice assigns evaluation and prescribing to OpenLoop Healthcare Partners, PC and its affiliated professional practices. Trinity Meds expressly says it does not provide medical advice, diagnosis or treatment and does not dispense medication. A branded website therefore should not be mistaken for the legal identity of the treating practice.
The terms advertise service in all 50 states and the District of Columbia, limited to people located within the United States. The FAQ adds an important qualification: provider availability and prescribing authority vary by state, and it says the assigned clinician will be licensed in the patient's state of residence. These are provider representations, not independently verified licensing findings. Before enrollment, identify the actual clinical practice and the contact route for medical concerns. Our guide to clinicians and telehealth platforms explains why that distinction matters when responsibility crosses organizational boundaries.
The assessment opens the process; it does not secure a prescription
The entry assessment is advertised as free, without obligation and approximately two minutes long. It asks for height, weight and target weight, explaining that those figures help calculate BMI and build a treatment profile. Enrollment requires being at least 18, and the platform says it does not prescribe GLP-1 medication to minors. Its FAQ describes review of medical history, current medications and contraindications, including personal or family history of medullary thyroid carcinoma or MEN2. The consulted documentation does not publish a numerical entry BMI threshold or a complete exclusion list.
The clinical notice requires a telehealth consultation before any prescription and leaves prescribing entirely to the clinician; approval is never guaranteed. That consultation can be live video or asynchronous review, depending on the clinician and state requirements. Promotional language saying many patients are prescribed immediately after assessment, with a call available “if needed,” is less precise about this mandatory clinical step. Ask which consultation format applies and when clinical review occurs relative to payment. A useful first-consultation checklist can help organize questions without assuming that a brief intake establishes eligibility.
Identify the preparation before interpreting the offer
The documented treatment options are compounded semaglutide and compounded tirzepatide, with injectable formulations available when clinically appropriate. The site describes subcutaneous administration and a kit containing syringes, needles and alcohol swabs. However, the consulted documentation does not establish the formulation, concentration, presentation or quantity corresponding to each advertised price, nor the supply period of each shipment. Mentions of branded drugs elsewhere do not establish that those products are included. The useful next step is to request the precise prescription and dispensing details, not infer them from an ingredient name or monthly marketing label.
Trinity Meds says preparations come from state-licensed 503A compounding pharmacies and claims USP 797 conditions and purity and potency testing; this review does not verify those claims or batch results. Compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. Nonapproval alone does not establish clinical inequivalence. FDA recommends compounded drugs when an individual's medical needs cannot be met by an approved drug, with a prescription and state-licensed pharmacy. That is clinical context, not an endorsement or condemnation of Trinity Meds or a categorical legal determination.
Follow the prescription into a specific pharmacy
The website names RedRock Pharmacy in St. George, Utah; Health Warehouse in Florence, Kentucky; Precision Medicine in Bellmore, New York; and Triad Rx in Daphne, Alabama. Listing these businesses does not establish which one would receive an individual prescription, independently verify its license or show that every listed partner compounds every offered preparation. The terms also allow a prescription to be sent to a pharmacy the patient chooses. They do not explain how that choice affects the bundled charge or whether medication costs at an outside pharmacy remain included.
The pharmacy handoff deserves its own confirmation rather than being treated as an automatic consequence of approval. Obtain the dispensing pharmacy's name, a working contact route and the prescription details before relying on a delivery estimate. The terms warn that pharmacy products may not come in child-resistant packaging or containers, a practical detail absent from the headline offer. Our pharmacy-handoff guide explains the difference between a prescribing decision and dispensing. The responsibility map below reflects the provider's documents, not independently verified performance or a guarantee that every handoff occurs without delay.
| Stage | Documented responsible party | What to confirm |
|---|---|---|
| Website and commercial access | Trinity Meds | Account support and subscription details |
| Telehealth technology | Openloop, Inc., also described as CareGLP | Portal access and message routing |
| Clinical evaluation and prescribing | OpenLoop Healthcare Partners, PC and affiliated practices | Assigned clinician and consultation format |
| Prescription dispensing | An outside pharmacy | Assigned pharmacy, preparation and shipment details |
| Patient-selected pharmacy | A pharmacy chosen by the patient, where elected | Effect on bundled pricing and medication charges |
Approval, dispatch and arrival have different clocks
Trinity Meds publishes more than one logistical estimate. One promotional block says free shipping and arrival in 1–2 days without clearly stating when that clock starts. Another describes a prescription within one day, an order shipping in 1–2 days and expedited delivery. The FAQ instead gives approximately 4–5 business days for typical processing and delivery after a clinician determines treatment is appropriate. These statements should not be collapsed into a single delivery promise: clinical approval, pharmacy processing, dispatch and arrival are different events, and no estimate guarantees a prescription.
The consulted documentation does not clarify the carrier, refrigeration method, transit-storage protections or a detailed lost-or-delayed shipment procedure. Its policy says damaged items may be replaced after evidence of damage and incorrect items will be replaced; replacement, not refund, is the stated remedy in both cases. That commercial policy does not resolve whether a temperature-sensitive shipment is suitable to use. FDA explicitly advises not using an injectable GLP-1 drug that arrives warm or with insufficient refrigeration and contacting the provider or dispensing pharmacy. The warm-delivery guide provides context for that advice without substituting for pharmacy instructions.
Ongoing access is described more clearly than the follow-up schedule
Trinity Meds advertises 24/7 access to a dedicated specialist team, unlimited appointments, messaging, support and check-ins. The contact page calls the patient portal the fastest route for account, prescription and health-related questions. For general, nonurgent inquiries, it asks users to allow up to 48 hours for a response and lists +1 253-650-6969. These statements describe access channels, not a guaranteed immediate clinical response. They also do not establish that every person answering a message is a prescribing clinician or that the general contact channel is appropriate for urgent concerns.
The membership description includes a personalized care plan, but the consulted pages do not specify mandatory review frequency, required laboratory tests or a detailed clinical escalation process. The subscription policy includes laboratory services “where applicable” without settling which tests apply or possible additional costs. NIDDK describes follow-up as involving response and tolerability, not simply continued payment. Before enrollment, ask who reviews symptoms, how clinician appointments are arranged and what happens when a concern needs more than a support message. Those answers would make the broad promise of unlimited access more useful in practice.
The monthly offer does not fully define the care package
Advertising places GLP-1 at $99 per month and GLP-1/GIP at $149 per month, with another offer explicitly calling them starting prices. The homepage promises the same monthly price “For Life,” no membership fees and no surprise increases, yet also displays a previous $299 price and a price-increase countdown. A fall promotion expires October 22 at midnight without naming a year. These conflicting messages do not establish a reliable price lock. Nor do the consulted pages identify different introductory and subsequent charges or connect each price to a specific compounded formulation, presentation and supply quantity.
The membership includes telehealth consultations, a personalized plan, prescription fulfillment when appropriate and shipping; the subscription policy describes a single bundled price rather than separately refundable components. Recurring charges follow intervals disclosed at checkout. Multi-month plans are contemplated, but their actual prices and durations are not established here. “No insurance required” is not the whole insurance position: the terms prohibit seeking or receiving reimbursement from federal, state or private healthcare payors for these services or products. The site also advertises FSA eligibility, which is a provider claim rather than a guarantee about an individual's account or tax treatment.
Leaving the subscription is separate from resolving clinical care
Cancellation can be requested at care@trinitymeds.com, by calling +1 253-650-6969 or through the account or patient portal if available. The cancellation policy requires receipt at least 72 hours before the next billing date; requests inside that window trigger another nonrefundable charge and take effect the following cycle. The terms instead permit cancellation up to 48 hours before monthly processing. The policy is marked August 25, 2026, and the terms May 6, 2026, but those dates do not themselves resolve the conflicting rules. Obtain the applicable deadline and cancellation confirmation in writing.
Payments are generally final and nonrefundable, including when intake is unfinished, a consultation is missed or a prescription is not filled or accepted. Multi-month purchases carry an explicit full-term commitment without prorating unused months, services or unshipped medication. Medical disqualification is an exception: if a clinician finds the patient ineligible, the subscription is canceled and the unused portion is refunded after deducting services already rendered. This is not necessarily a full refund. The distinction matters when planning a care transition: stopping future charges, recovering past payments and arranging clinical follow-up are separate tasks.
Questions & answers
Does the free Trinity Meds assessment establish a clinical relationship?
Not with Trinity Meds, according to its clinical notice. The assessment is advertised as free and without obligation, but clinical evaluation and prescribing belong to OpenLoop Healthcare Partners, PC and affiliated practices. A clinician must complete a telehealth consultation before prescribing. The consultation can be asynchronous, so the absence of a video call does not by itself establish that clinical review was skipped.
Does $99 buy a clearly specified semaglutide supply?
The consulted documentation does not establish that. It advertises GLP-1 from $99 per month and documents compounded injectable semaglutide as an available treatment, but does not connect that price to a precise concentration, presentation, quantity or shipment supply period. Ask for the complete product and billing details at checkout. A monthly advertised amount alone does not establish how much medication each delivery contains.
Can I choose a pharmacy outside Trinity Meds' listed partners?
The terms expressly allow an issued prescription to be sent to a pharmacy of the patient's choice instead of a pharmacy accessible through the service. The financial consequences are not explained: the documentation does not establish whether the bundle changes or whether an outside pharmacy would charge separately. Confirm acceptance, dispensing availability and payment responsibilities before assuming that this option preserves the advertised all-in arrangement.
Will Trinity Meds medication arrive within two days?
That should not be treated as a settled service promise. Advertising says arrival in 1–2 days, another block describes dispatch in 1–2 days, and the FAQ gives approximately 4–5 business days for processing and delivery. Ask which estimate applies to the actual order and what event starts the clock. A dispatch estimate is not an arrival estimate, and clinical approval remains a separate prerequisite.
Does canceling mean I get my payment back?
Generally no. The policy separates cancellation of future billing from refunds and makes payments final except for medical disqualification. That exception refunds only the unused portion after deducting services already delivered. The conflicting 72-hour and 48-hour cancellation deadlines also matter: the policy says a request inside its 72-hour window produces another nonrefundable charge. Seek written confirmation rather than relying only on the phrase “cancel at any time.”
Do Trinity Meds' weight-loss figures verify its treatment results?
The website says its figures come from members' self-reported data, not clinical trials or peer-reviewed studies. Its promotion also discloses that a featured person received discounted, complimentary or compensated services and that testimonials may not represent typical outcomes. Those disclosures limit what the examples establish. They do not independently verify the effectiveness of this service or predict an individual patient's result.
Our assessment
Trinity Meds documents a recognizable care pathway: an initial assessment, clinician-led telehealth evaluation, conditional prescribing, outside-pharmacy dispensing and portal-based support. Naming the clinical organizations and pharmacy partners, permitting pharmacy choice and publishing refund rules provide useful starting points for scrutiny. However, the public account is not yet a fully specified service commitment. Conflicting consultation language, delivery estimates, price promises and cancellation deadlines affect practical decisions, while the exact preparation, shipment quantity, assigned pharmacy and follow-up schedule remain unresolved. Before paying, request a written summary covering those points, the checkout billing interval and the applicable cancellation deadline. This documentary review establishes what the business says it offers, not independently verified licensing, pharmacy quality, clinical performance or suitability for an individual.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Trinity Meds — about ↗
- Trinity Meds — contact ↗
- Trinity Meds — consultation ↗
- Trinity Meds — m2/refund cancellation policy ↗
- Trinity Meds — m1/offer v9 tm ↗
- Trinity Meds — official website ↗
- Trinity Meds — m2/terms and conditions ↗